Wire · opportunities
Eli Lilly's diabetes drug Mounjaro gets approval for a new use
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 29 August 2026 · Fusion42 review
The FDA approved Eli Lilly's diabetes drug Mounjaro for reducing the risk of heart attack or stroke in high-risk adults with Type 2 diabetes, expanding its therapeutic use beyond blood sugar control.
This Wire brief sits within Fusion42's coverage of Biotech, and 20 sources have reported it between 28 Aug 2026 and 1 Sep 2026.
◆ ◆ The Wire takeaway
You now face an expanded market opportunity as Mounjaro’s new FDA approval opens heart-risk reduction treatment to type 2 diabetes patients. This regulatory green light creates a direct route for patient access, changing competitive positioning around cardiovascular and diabetes care.
◆ Coverage
20 sources · first reported 28 Aug 2026 · latest 1 Sep 2026
◆ Topics